Search Results - "Renzulli, Cecilia"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Rifaximin: beyond the traditional antibiotic activity by Calanni, Fiorella, Renzulli, Cecilia, Barbanti, Miriam, Viscomi, Giuseppe Claudio

    Published in Journal of antibiotics (01-09-2014)
    “…Rifaximin is a non-systemic oral antibiotic derived from rifampin and characterized by a broad spectrum of antibacterial activity against Gram-positive and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Evaluation of Antioxidant Activity of Some Natural Polyphenolic Compounds Using the Briggs−Rauscher Reaction Method by Cervellati, Rinaldo, Renzulli, Cecilia, Guerra, Maria Clelia, Speroni, Ester

    Published in Journal of agricultural and food chemistry (18-12-2002)
    “…A new method based on the inhibitory effects of antioxidants on the oscillations of the hydrogen peroxide, acidic iodate, malonic acid, and Mn(II)-catalyzed…”
    Get full text
    Journal Article
  5. 5

    Disposition and Metabolism of [14C]SB-649868, an Orexin 1 and 2 Receptor Antagonist, in Humans by RENZULLI, Cecilia, NASH, Mike, WRIGHT, Mark, THOMAS, Steven, ZAMUNER, Stefano, PELLEGATTI, Mario, BETTICA, Paolo, BOYLE, Gary

    Published in Drug metabolism and disposition (01-02-2011)
    “…N-[[(2S)-1-[[5-(4-fluorophenyl)-2-methyl-4-thiazolyl]carbonyl]-2-piperidinyl]methyl]-4-benzofurancarboxamide (SB-649868) is a novel orexin 1 and 2 receptor…”
    Get full text
    Journal Article
  6. 6

    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans by Scarpignato, Carmelo, Dolak, Werner, Lanas, Angel, Matzneller, Peter, Renzulli, Cecilia, Grimaldi, Maria, Zeitlinger, Markus, Bjarnason, Ingvar

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-2017)
    “…The intestinal microbiota might contribute to enteropathy associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs), but there have been few human…”
    Get full text
    Journal Article
  7. 7

    Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double‐blind, randomised, placebo‐controlled, phase 2 study by Kuo, Braden, Barnes, Chris N., Nguyen, Deanna D., Shaywitz, David, Grimaldi, Maria, Renzulli, Cecilia, Canafax, Daniel, Parkman, Henry P.

    Published in Alimentary pharmacology & therapeutics (01-05-2021)
    “…Summary Background Gastroparesis is a serious gastrointestinal (GI) condition characterised by delayed gastric emptying (GE). Velusetrag—a potent, selective,…”
    Get full text
    Journal Article
  8. 8

    Editorial: on the road towards treatment of gastroparesis—accelerating, but do we get closer? Authors' reply by Kuo, Braden, Barnes, Chris N., Nguyen, Deanna D., Shaywitz, David, Grimaldi, Maria, Renzulli, Cecilia, Canafax, Daniel, Parkman, Henry P.

    Published in Alimentary pharmacology & therapeutics (01-07-2021)
    “…LINKED CONTENT This article is linked to Kuo et al and Wuestenberghs & Gourcerol papers. To view these articles, visit https://doi.org/10.1111/apt.16344 and…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Rifaximin Reduces Number and Severity of Intestinal Lesions Associated With use of Non-steroidal Anti-inflammatory Drugs in Humans by Scarpignato, Carmelo, Dolak, Werner, Lanas, Angel, Matzneller, Peter, Renzulli, Cecilia, Grimaldi, Maria, Zeitlinger, Markus, Bjarnason, Ingvar

    “…Abstract The intestinal microbiota might contribute to enteropathy associated with use of non-steroidal anti-inflammatory drugs (NSAIDs), but there have been…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15